Scientists use radioactive tracer to map breast cancer Drug's journey
NCT ID NCT04940026
First seen Nov 01, 2025 · Last updated May 03, 2026 · Updated 28 times
Summary
This study looked at how a breast cancer drug called SAR439859 is absorbed, broken down, and removed from the body. Six healthy postmenopausal women took a single dose of the drug with a tiny radioactive marker. Researchers measured the drug in blood, urine, and stool to understand its metabolism and how much reaches the bloodstream.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 8260001
Nottingham, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.